In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes
- PMID: 197019
- PMCID: PMC421126
- DOI: 10.1128/iai.17.2.350-355.1977
In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes
Abstract
Inhibition of herpesvirus plaque growth was observed when herpes simplex virus (HSV)-sensitized rabbit lymphocytes were placed in contact with an HSV-infected human foreskin monolayer. This inhibition was obtained as early as 3 h when a ratio of 6 viable lymphocytes to target cells was used, and the supernatants of these cultures also demonstrated plaque size reduction when put onto newly infected cell monolayers. Interferon, which is present in this system, had no effect on HSV when tested on human foreskin monolayers, indicating that interferon was not the mechanism for plaque size reduction. Plaque growth inhibition was attributed to the T lymphocyte, because purified T cells reduced plaque growth and anti-rabbit thymocyte serum eliminated the effect of T cells. The specificity of this assay was determined by the facts that nonsensitized lymphocytes did not reduce the size of a plaque and the recognition of an infected cell by the sensitized lymphocyte was necessary for the release of a soluble mediator into the supernatant fluid. This cytotoxic lymphocyte was detected in the peripheral blood of rabbits as early as 4 days after initial corneal infection, with a maximum response at 7 to 10 days.
Similar articles
-
Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon.Infect Immun. 1980 Jun;28(3):708-12. doi: 10.1128/iai.28.3.708-712.1980. Infect Immun. 1980. PMID: 6156904 Free PMC article.
-
Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.J Gen Virol. 1992 Nov;73 ( Pt 11):2949-54. doi: 10.1099/0022-1317-73-11-2949. J Gen Virol. 1992. PMID: 1279103
-
Cellular immunity to herpes simplex virus mediated by interferon.J Exp Med. 1974 Sep 1;140(3):764-78. doi: 10.1084/jem.140.3.764. J Exp Med. 1974. PMID: 4369835 Free PMC article.
-
Inhibition of Herpesvirus hominis replication by human interferon.Infect Immun. 1975 Jul;12(1):104-8. doi: 10.1128/iai.12.1.104-108.1975. Infect Immun. 1975. PMID: 166922 Free PMC article.
-
Herpes simplex virus and the rheumatic diseases.Rheumatol Int. 1989;9(3-5):143-6. doi: 10.1007/BF00271871. Rheumatol Int. 1989. PMID: 2481873 Review.
Cited by
-
Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.Arch Virol. 1982;74(2-3):135-44. doi: 10.1007/BF01314707. Arch Virol. 1982. PMID: 6299234
-
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.Infect Immun. 1980 Aug;29(2):642-9. doi: 10.1128/iai.29.2.642-649.1980. Infect Immun. 1980. PMID: 7216431 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources